Search for a doctor

Timothy S. Larson, M.D.

  1. Clinical Informaticist
  2. Internist
  3. Nephrologist
Request an Appointment

Publications

  1. Kaur RJ, Mujtahedi SS, Fridell JA, Benavides X, Smith B, Larson TS, Rizvi SR, Kukla A, Dean P, Kudva YC, Odorico J, Stegall M. Impact of pancreas transplantation alone on kidney function: A multicenter clinical cohort study. Clin Transplant. 2024 Jan; 38 (1):e15212 Epub 2023 Dec 01
    View PubMed
  2. Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prie D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ. 2023 May 31; 381:e073654
    View PubMed
  3. Meeusen JW, Kasozi RN, Larson TS, Lieske JC. Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation. Clin Chem. 2022 Mar 31; 68 (4):534-539
    View PubMed
  4. Gharaibeh KA, Hamadah AM, El-Zoghby ZM, Lieske JC, Larson TS, Leung N. Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury. Kidney Int Rep. 2018 Mar; 3 (2):337-342 Epub 2017 Nov 03
    View PubMed
  5. Zand L, Torres VE, Larson TS, King BF, Sethi S, Bergstralh EJ, Angioi A, Fervenza FC. Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2016 Aug; 31 (8):1290-5 Epub 2015 Nov 27
    View PubMed
  6. Seegmiller JC, Burns BE, Schinstock CA, Lieske JC, Larson TS. Discordance Between Iothalamate and Iohexol Urinary Clearances. Am J Kidney Dis. 2016 Jan; 67 (1):49-55 Epub 2015 Oct 09
    View PubMed
  7. Amer H, Griffin MD, Stegall MD, Cosio FG, Park WD, Kremers WK, Heilman RL, Mazur MJ, Hamawi K, Larson TS, Kumar R. Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. Am J Transplant. 2013 Jun; 13 (6):1576-85 Epub 2013 Apr 19
    View PubMed
  8. Schinstock CA, Semret MH, Wagner SJ, Borland TM, Bryant SC, Kashani KB, Larson TS, Lieske JC. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol Dial Transplant. 2013 May; 28 (5):1175-85 Epub 2012 Apr 23
    View PubMed
  9. Amer H, Lieske JC, Rule AD, Kremers WK, Larson TS, Franco Palacios CR, Stegall MD, Cosio FG. Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant. 2013 Mar; 13 (3):676-84 Epub 2013 Feb 15
    View PubMed
  10. Park WD, Larson TS, Griffin MD, Stegall MD. Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function. Transplantation. 2012 Nov 15; 94 (9):931-9
    View PubMed
  11. Voskoboev NV, Larson TS, Rule AD, Lieske JC. Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate. Clin Chem Lab Med. 2012 Mar 30; 50 (9):1591-6
    View PubMed
  12. Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC. Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol. 2011 Aug; 6 (8):1963-72 Epub 2011 July 07
    View PubMed
  13. Lorenz EC, Stegall MD, Cosio FG, Gloor JM, Larson TS, Taler SJ. The effect of coronary angiography on renal function in preemptive renal transplant candidates. Clin Transplant. 2011 Jul-Aug; 25: (4)594-9.
    View PubMed
  14. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  15. Stegall MD, Park WD, Larson TS, Gloor JM, Cornell LD, Sethi S, Dean PG, Prieto M, Amer H, Textor S, Schwab T, Cosio FG. The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant. 2011 Apr; 11 (4):698-707 Epub 2010 Nov 09
    View PubMed
  16. Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transpl Int. 2010 May 1; 23(5):506-13. Epub 2009 Nov 27.
    View PubMed
  17. Seegmiller JC, Burns BE, Fauq AH, Mukhtar N, Lieske JC, Larson TS. Iothalamate quantification by tandem mass spectrometry to measure glomerular filtration rate. Clin Chem. 2010 Apr; 56 (4):568-74 Epub 2010 Feb 18
    View PubMed
  18. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010 Apr; 52 (4):523-8 Epub 2010 Feb 04
    View PubMed
  19. Leung N, Shaikh A, Cosio FG, Griffin MD, Textor SC, Gloor JM, Schwab TR, Larson TS, Dean PG, Prieto M, Nyberg SL, Stegall MD, Lee CU, Pittelkow MR. The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. Am J Transplant. 2010 Mar; 10 (3):558-62 Epub 2010 Jan 05
    View PubMed
  20. Leung N, Shaikh A, Cosio FG, Griffin MD, Textor SC, Gloor JM, Schwab TR, Larson TS, Dean PG, Prieto M, Nyberg SL, Stegall MD, Lee CU, Pittelkow MR. The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. J Urol. 2010; 184(4):1440.
  21. Seegmiller JC, Sviridov D, Larson TS, Borland TM, Hortin GL, Lieske JC. Comparison of urinary albumin quantification by immunoturbidimetry, competitive immunoassay, and protein-cleavage liquid chromatography-tandem mass spectrometry. Clin Chem. 2009 Nov; 55 (11):1991-4 Epub 2009 Sept 10
    View PubMed
  22. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant. 2009 Aug; 9 (8):1894-902 Epub 2009 June 10
    View PubMed
  23. Seegmiller JC, Barnidge DR, Burns BE, Larson TS, Lieske JC, Kumar R. Quantification of urinary albumin by using protein cleavage and LC-MS/MS. Clin Chem. 2009 Jun; 55 (6):1100-7 Epub 2009 Mar 26
    View PubMed
  24. Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation. 2009 Apr 27; 87 (8):1232-9
    View PubMed
  25. Shaikh A, Seegmiller JC, Borland TM, Burns BE, Ladwig PM, Singh RJ, Kumar R, Larson TS, Lieske JC. Comparison between immunoturbidimetry, size-exclusion chromatography, and LC-MS to quantify urinary albumin. Clin Chem. 2008 Sep; 54(9):1504-10. Epub 2008 Jul 10.
    View PubMed
  26. Dean PG, Grande JP, Sethi S, Park WD, Griffin MD, Cosio FG, Larson TS, Stegall MD. Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. Transplantation. 2008 Apr 27; 85(8):1212-5.
    View PubMed
  27. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008 Jan; 8 (1):175-82 Epub 2007 Oct 31
    View PubMed
  28. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, Stegall MD, Cosio FG. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant. 2007 Dec; 7 (12):2748-56 Epub 2007 Oct 17
    View PubMed
  29. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant. 2007 Sep; 7 (9):2124-32 Epub 2007 July 03
    View PubMed
  30. Khamash HA, Wadei HM, Mahale AS, Larson TS, Stegall MD, Cosio FG, Griffin MD. Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int. 2007 Jun; 71 (12):1302-9 Epub 2007 Apr 04
    View PubMed
  31. Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, Larson TS, Schwab TR, Stegall MD, Textor SC. Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol. 2007 May; 18: (5)1607-15.
    View PubMed
  32. Gera M, Slezak JM, Rule AD, Larson TS, Stegall MD, Cosio FG. Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant. 2007 Apr; 7 (4):880-7
    View PubMed
  33. Cosio FG, Amer H, Grande JP, Larson TS, Stegall MD, Griffin MD. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation. 2007 Feb 27; 83 (4):411-6
    View PubMed
  34. Innocenti GR, Wadei HM, Prieto M, Dean PG, Ramos EJ, Textor S, Khamash H, Larson TS, Cosio F, Kosberg K, Fix L, Bauer C, Stegall MD. Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation. 2007 Jan 27; 83(2):144-9.
    View PubMed
  35. Klee GG, Schryver PG, Saenger AK, Larson TS. Effects of analytic variations in creatinine measurements on the classification of renal disease using estimated glomerular filtration rate (eGFR). Clin Chem Lab Med. 2007; 45: (6)737-41.
    View PubMed
  36. Babic N, Larson TS, Grebe SK, Turner ST, Kumar R, Singh RJ. Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin Chem. 2006 Nov; 52 (11):2155-7
    View PubMed
  37. Rule AD, Rodeheffer RJ, Larson TS, Burnett JC Jr, Cosio FG, Turner ST, Jacobsen SJ. Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc. 2006 Nov; 81(11):1427-34.
    View PubMed
  38. Rea DJ, Heimbach JK, Grande JP, Textor SC, Taler SJ, Prieto M, Larson TS, Cosio FG, Stegall MD. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int. 2006 Nov; 70 (9):1636-41 Epub 2006 Sept 06
    View PubMed
  39. Davies JL, Clark VM, Litchy WJ, Dyck PJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ 3rd, O'Brien PC. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006 Oct; 29 (10):2282-8
    View PubMed
  40. Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant. 2006 Sep; 21 (9):2607-14 Epub 2006 May 16
    View PubMed
  41. Myslak M, Amer H, Morales P, Fidler ME, Gloor JM, Larson TS, Stegall MD, Cosio FG. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant. 2006 Jul; 6 (7):1660-5
    View PubMed
  42. Wadei HM, Rule AD, Lewin M, Mahale AS, Khamash HA, Schwab TR, Gloor JM, Textor SC, Fidler ME, Lager DJ, Larson TS, Stegall MD, Cosio FG, Griffin MD. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant. 2006 May; 6 (5 Pt 1):1025-32
    View PubMed
  43. Larson TS, Dean PG, Stegall MD, Griffin MD, Textor SC, Schwab TR, Gloor JM, Cosio FG, Lund WJ, Kremers WK, Nyberg SL, Ishitani MB, Prieto M, Velosa JA. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant. 2006 Mar; 6 (3):514-22
    View PubMed
  44. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006 Jan; 69 (2):399-405
    View PubMed
  45. Ladwig PM, Liedtke RR, Larson TS, Lieske JC. Sensitive spectrophotometric assay for plasma oxalate. Clin Chem. 2005 Dec; 51(12):2377-80.
    View PubMed
  46. Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG, Stegall MD, McGregor CG. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol. 2005 Oct 20; 23 (30):7574-82 Epub 2005 Sept 26
    View PubMed
  47. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant. 2005 Oct; 5 (10):2464-72
    View PubMed
  48. Leung N, Griffin MD, Dispenzieri A, Haugen EN, Gloor JM, Schwab TR, Textor SC, Lacy MQ, Litzow MR, Cosio FG, Larson TS, Gertz MA, Stegall MD. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant. 2005 Jul; 5 (7):1660-70
    View PubMed
  49. Casey ET, Smyrk TC, Burgart LJ, Stegall MD, Larson TS. Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens. Transplantation. 2005 Jun 27; 79 (12):1717-22
    View PubMed
  50. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005 Jun; 67 (6):2415-21
    View PubMed
  51. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant. 2005 May; 5 (5):1057-64
    View PubMed
  52. Cosio FG, Grande JP, Larson TS, Gloor JM, Velosa JA, Textor SC, Griffin MD, Stegall MD. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant. 2005 May; 5 (5):1130-6
    View PubMed
  53. Ghobrial IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, Ansell SM, Gores GJ, Stegall MD, McGregor CG. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation. 2005 Jan 27; 79 (2):244-7
    View PubMed
  54. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004 Dec 21; 141 (12):929-37
    View PubMed
  55. de la Vega LSP, Torres A, Bohorquez HE, Heimbach JK, Gloor JM, Schwab TR, Taler SJ, Nyberg SL, Ishitani MB, Prieto M, Velosa JA, Larson TS, Stegall MD, Cosio FG, Textor SC, Griffin MD. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int. 2004 Oct; 66(4):1654-61.
    View PubMed
  56. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, Cosio F, Schwab T, Prieto M, Nyberg S, Ishitani M, Stegall M. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation. 2004 Jul 27; 78 (2):276-82
    View PubMed
  57. Atwell TD, Gorman B, Larson TS, Charboneau JW, Ingalls Hanson BM, Stegall MD. Pancreas transplants: experience with 232 percutaneous US-guided biopsy procedures in 88 patients. Radiology. 2004 Jun; 231: (3)845-9.
    View PubMed
  58. Dean PG, Lund WJ, Larson TS, Prieto M, Nyberg SL, Ishitani MB, Kremers WK, Stegall MD. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation. 2004 May 27; 77 (10):1555-61
    View PubMed
  59. Fervenza FC, Fitzpatrick PM, Mertz J, Erickson SB, Liggett S, Popham S, Wochos DN, Synhavsky A, Hippler S, Larson TS, Bagniewski SM, Velosa JA, Mayo Nephrology Collaborative Committee. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies. Nephrol Dial Transplant. 2004 May; 19(5):1288-92. Epub 2004 Feb 19.
    View PubMed
  60. Larson TS, Bohorquez H, Rea DJ, Nyberg SL, Prieto M, Sterioff S, Textor SC, Schwab TR, Griffin MD, Gloor JM, Kudva YC, Kremers WK, Stegall MD. Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation. 2004 Mar 27; 77 (6):838-43
    View PubMed
  61. Mazur MJ, Rea DJ, Griffin MD, Larson TS, Prieto M, Gloor JM, Schwab TR, Textor SC, Nyberg SL, Stegall MD. Decline in native renal function early after bladder-drained pancreas transplantation alone. Transplantation. 2004 Mar 27; 77 (6):844-9
    View PubMed
  62. Fidler ME, Gloor JM, Lager DJ, Larson TS, Griffin MD, Textor SC, Schwab TR, Prieto M, Nyberg SL, Ishitani MB, Grande JP, Kay PA, Stegall MD. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant. 2004 Jan; 4 (1):101-7
    View PubMed
  63. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis. 2004 Jan; 43 (1):112-9
    View PubMed
  64. Gyamlani GG, Bergstralh EJ, Slezak JM, Larson TS. Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus. Am J Kidney Dis. 2003 Oct; 42 (4):685-92
    View PubMed
  65. Buehrig CK, Lager DJ, Stegall MD, Kreps MA, Kremers WK, Gloor JM, Schwab TR, Velosa JA, Fidler ME, Larson TS, Griffin MD. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int. 2003 Aug; 64(2):665-73.
    View PubMed
  66. Textor SC, Taler SJ, Larson TS, Prieto M, Griffin M, Gloor J, Nyberg S, Velosa J, Schwab T, Stegall M. Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol. 2003 Aug; 14 (8):2159-67
    View PubMed
  67. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, Larson TS, Griffin MD, Textor SC, Velosa JA, Schwab TR, Fix LA, Stegall MD. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant. 2003 Aug; 3 (8):1017-23
    View PubMed
  68. Nyberg SL, Matas AJ, Kremers WK, Thostenson JD, Larson TS, Prieto M, Ishitani MB, Sterioff S, Stegall MD. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant. 2003 Jun; 3 (6):715-21
    View PubMed
  69. Stegall MD, Larson TS, Prieto M, Gloor J, Textor S, Nyberg S, Sterioff S, Ishitani M, Griffin M, Kremers W, Lund W, Schwab T, Cosio F, Velosa J. Kidney transplantation without calcineurin inhibitors using sirolimus. Transplant Proc. 2003 May; 35 (3 Suppl):125S-127S
    View PubMed
  70. Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, Grande JP, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Velosa JA, Textor SC, Platt JL, Stegall MD. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation. 2003 Apr 15; 75 (7):971-7
    View PubMed
  71. Ladwig PM, Bergert JH, Larson TS. Capillary electrophoresis method to measure p-aminohippuric acid in urine and plasma for the assessment of renal plasma flow. Clin Chem. 2003 Apr; 49 (4):664-6
    View PubMed
  72. Morgenstern BZ, Butani L, Wollan P, Wilson DM, Larson TS. Validity of protein-osmolality versus protein-creatinine ratios in the estimation of quantitative proteinuria from random samples of urine in children. Am J Kidney Dis. 2003 Apr; 41 (4):760-6
    View PubMed
  73. Haydar A, Covic A, Agharazii M, Jayawardene S, Goldsmith D, Larson T. Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant. 2003; 4:244-7.
  74. Gloor JM, Cohen AJ, Lager DJ, Grande JP, Fidler ME, Velosa JA, Larson TS, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Sterioff S, Kremers WK, Stegall MD. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation. 2002 Jun 27; 73 (12):1965-8
    View PubMed
  75. Reeder GS, Holmes DR, Holmes DR, Lennon RJ, Larson TS, Frye RL. Proteinuria, serum creatinine, and outcome of percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol. 2002 Mar 15; 89 (6):760-4
    View PubMed
  76. Velosa JA, Griffin MD, Larson TS, Gloor JM, Schwab TR, Sterioff S, Bergstralh EJ, Stegall MD. Can a transplanted living donor kidney function equivalently to its native partner? Am J Transplant. 2002 Mar; 2 (3):252-9
    View PubMed
  77. Abraham RS, Clark RJ, Bryant SC, Lymp JF, Larson T, Kyle RA, Katzmann JA. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clin Chem. 2002; 48(4):655-7.
    View PubMed
  78. Stegall MD, Larson TS, Prieto M, Gloor J, Textor S, Nyberg S, Sterioff S, Ishitani M, Griffin M, Schwab T, Talor S, Cosio F, Kudva Y, Dicke-Henslin D, Kreps M, Fix L, Bauer C, Murphy M, Kosberg K, Tarara D, Velosa J. Living-donor kidney transplantation at Mayo Clinic--Rochester. Clin Transpl. 2002:155-61.
  79. Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis. 2001 Dec 1; 184(11):1461-4. Epub 2001 Oct 23.
    View PubMed
  80. Stegall MD, Kim DY, Prieto M, Cohen AJ, Griffin MD, Schwab TR, Nyberg SL, Velosa JA, Gloor JM, Innocenti F, Bohorquez H, Dean PG, Carpenter HA, Leontovich ON, Sterioff S, Larson TS. Thymoglobulin induction decreases rejection in solitary pancreas transplantation. Transplantation. 2001 Nov 27; 72 (10):1671-5
    View PubMed
  81. Velosa JA, Pach JM, Sterioff S, Larson TS, Norell JE, O'Brien PC, Dyck PJ, Dyck PJ. Increased weakness after pancreas and kidney transplantation. Transplantation. 2001 Oct 27; 72 (8):1403-8
    View PubMed
  82. Velosa JA, Larson TS, Gloor JM, Stegall MD. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety. Am J Kidney Dis. 2001 Oct; 38 (4 Suppl 2):S3-S10
    View PubMed
  83. Stegall MD, Kim DY, Larson TS. Immunosuppression in pancreas transplantation. Graft. 2001 Oct-November; 4(7):500-7.
  84. Nyberg SL, Matas AJ, Rogers M, Harmsen WS, Velosa JA, Larson TS, Prieto M, Ishitani MB, Sterioff S, Stegall MD. Donor scoring system for cadaveric renal transplantation. Am J Transplant. 2001 Jul; 1 (2):162-70
    View PubMed
  85. Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol. 2001 Apr; 12 (4):791-799
    View PubMed
  86. Cohen AJ, Larson TS, Dean P, Logan J, Dean P, Diamond L, McGregor CG, Stegall MD. Renal physiology in pig-to-baboon xenografts. Transplant Proc. 2001 Feb-Mar; 33 (1-2):727-8
    View PubMed
  87. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000 Dec; 75(12):1275-83.
    View PubMed
  88. Albright RC Jr, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc. 2000 Nov; 75(11):1141-7.
    View PubMed
  89. Kiberd BA, Larson T. Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis. Transplantation. 2000 Oct 15; 70(7):1121-7.
    View PubMed
  90. Dyck PJ, Dyck PJB, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care. 2000 Apr; 23 (4):510-7
    View PubMed
  91. Stegall MD, Larson TS, Kudva YC, Grande JP, Nyberg SL, Prieto M, Velosa JA, Rizza RA. Pancreas transplantation for the prevention of diabetic nephropathy. Mayo Clin Proc. 2000 Jan; 75(1):49-56.
    View PubMed
  92. Larson TS, Santanello N, Shahinfar S, O'Brien PC, Palumbo PJ, Melton LJ 3rd, Melton LJ 3rd, Leibson CL. Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care. 2000 Jan; 23 (1):51-6
    View PubMed
  93. Pflueger AC, Larson TS, Hagl S, Knox FG. Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol. 1999 Sep; 277 (3):R725-33
    View PubMed
  94. Pflueger AC, Larson TS, Hagl S, Knox FG. Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am J Physiol Regul Integr Comp Physiol. 1999 Sep 1; 277 (3):R725-R733
    View PubMed
  95. Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol. 1999 Aug; 10 (8):1772-7
    View PubMed
  96. Wilson DM, Bergert JH, Larson TS, Liedtke RR. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis. 1997 Nov; 30 (5):646-52
    View PubMed
  97. Radford MG Jr, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, McCarthy JT. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA. 1996 Aug 14; 276 (6):466-9
    View PubMed
  98. Golconda MS, Larson TS, Kolb LG, Kumar R. 1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient. Mayo Clin Proc. 1996 Jan; 71 (1):32-6
    View PubMed
  99. Griffin MD, Bergstralhn EJ, Larson TS. Renal papillary necrosis--a sixteen-year clinical experience. J Am Soc Nephrol. 1995 Aug; 6 (2):248-56
    View PubMed
  100. Larson TS, Lockhart JC. Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine. Am J Physiol. 1995 May; 268 (5 Pt 2):F907-12
    View PubMed
  101. Larson TS. Evaluation of proteinuria. Mayo Clin Proc. 1994 Dec; 69 (12):1154-8
    View PubMed
  102. Lockhart JC, Larson TS, Knox FG. Perfusion pressure and volume status determine the microvascular response of the rat kidney to NG-monomethyl-L-arginine. Circ Res. 1994 Nov; 75 (5):829-35
    View PubMed
  103. Chiang KS, Larson TS, Swee RG, Bostwick DG, LeRoy AH. CT of Erdheim-Chester disease presenting as retroperitoneal xanthogranulomatosis. J Comput Assist Tomogr. 1994 May-Jun; 18 (3):503-5
    View PubMed
  104. Wijdicks EF, Larson TS. Absence of postoperative hyponatremia syndrome in young, healthy females. Ann Neurol. 1994 May; 35(5):626-8.
    View PubMed
  105. Haas JA, Lockhart JC, Larson TS, Henrikson T, Knox FG. Natriuretic response to renal interstitial hydrostatic pressure during angiotensin II blockade. Am J Physiol. 1994 Jan; 266 (1 Pt 2):F117-9
    View PubMed
  106. Keith DS, Larson TS. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 1993 May; 3 (11):1748-52
    View PubMed
  107. Farrugia E, King BF, Larson TS. Magnetic resonance angiography and detection of renal artery stenosis in a patient with impaired renal function. Mayo Clin Proc. 1993 Feb; 68 (2):157-60
    View PubMed
  108. Farrugia E, Lockhart JC, Larson TS. Relation between vasa recta blood flow and renal interstitial hydrostatic pressure during pressure natriuresis. Circ Res. 1992 Nov; 71 (5):1153-8
    View PubMed
  109. Farrugia E, Larson TS. Drug-induced renal toxicity. Help in recognizing offending agents. Postgrad Med. 1991 Aug; 90 (2):241-4, 247-8
    View PubMed
  110. Jamison RL, Miyamoto M, Yagil Y, Larson TS, Myers B, Robertson C. The study of blood flow to renal inner medulla by fluorescence videomicroscopy: effect of adenosine. Excerpta Med Front of Nephrol. 1990; 877:205-214.
  111. Miyamoto M, Yagil Y, Larson T, Robertson C, Jamison RL. Effects of intrarenal adenosine on renal function and medullary blood flow in the rat. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1230-4.
    View PubMed
  112. Kiberd B, Robertson CR, Larson T, Jamison RL. Effect of V2-receptor-mediated changes on inner medullary blood flow induced by AVP. Am J Physiol. 1987 Sep; 253(3 Pt 2):F576-81.
    View PubMed
  113. Kiberd BA, Larson TS, Robertson CR, Jamison RL. Effect of atrial natriuretic peptide on vasa recta blood flow in the rat. Am J Physiol. 1987 Jun; 252(6 Pt 2):F1112-7.
    View PubMed
  114. Larson TS, Hall S, Hepper NG, Hunder GG. Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med. 1984 Nov; 101(5):594-7.
    View PubMed
  115. Larson TS, Hall S, Hepper NGG, Hunder GG. Respiratory tract symptoms as a clue to giant cell arteritis (GCA). Clin Res. 1984 Oct; 32:822A.
  116. Larson TS, Hudson K, Mertz JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med. 1983 Mar; 101(3):385-91.
    View PubMed
PST-20219533